Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
10.69
-0.03 (-0.28%)
Jun 29, 2026, 2:14 PM EDT - Market open
Phathom Pharmaceuticals Employees
Phathom Pharmaceuticals had 371 employees as of December 31, 2025. The number of employees decreased by 56 or -13.11% compared to the previous year.
Employees
371
Change (1Y)
-56
Growth (1Y)
-13.11%
Revenue / Employee
$552,270
Profits / Employee
-$423,989
Market Cap
849.11M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Geron | 258 |
| ARS Pharmaceuticals | 159 |
| Solid Biosciences | 121 |
| Aura Biosciences | 113 |
| Odyssey Therapeutics | 100 |
| Annexon | 93 |
| Theravance Biopharma | 90 |
| Inventiva | 77 |
PHAT News
- 6 days ago - Phathom Pharmaceuticals completes enrollment in pHalcon-EoE-201 clinical trial - TheFly
- 6 days ago - Phathom Pharmaceuticals Completes Patient Enrollment Ahead of Schedule in Phase 2 pHalcon-EoE-201 Study of VOQUEZNA® (vonoprazan) in Eosinophilic Esophagitis (EoE) - GlobeNewsWire
- 19 days ago - Phathom Pharmaceuticals Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 26 days ago - Phathom Pharmaceuticals Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 4 weeks ago - Needham pharmaceuticals analysts hold analyst/industry conference call - TheFly
- 5 weeks ago - Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 5 weeks ago - Phathom Pharmaceuticals Highlights Breadth of Independent Vonoprazan Research at Digestive Disease Week 2026 Annual Meeting - GlobeNewsWire
- 2 months ago - Phathom Pharmaceuticals to Highlight VOQUEZNA® (vonoprazan) at DDW 2026 Annual Meeting - GlobeNewsWire